Cargando…
Overexpression of TSC-22 (transforming growth factor-β-stimulated clone-22) causes marked obesity, splenic abnormality and B cell lymphoma in transgenic mice
In this study, we generated transgenic (Tg) mice, which overexpressed transforming growth factor (TGF)-β stimulated clone-22 (TSC-22), and investigate the functional role of TSC-22 on their development and pathogenesis. We obtained 13 Tg-founders (two mice from C57BL6/J and 11 mice from BDF1). Three...
Autores principales: | Uchida, Daisuke, Kawamata, Hitoshi, Omotehara, Fumie, Miwa, Yoshihiro, Horiuchi, Hideki, Furihata, Tadashi, Tachibana, Masatsugu, Fujimori, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924717/ https://www.ncbi.nlm.nih.gov/pubmed/26872059 http://dx.doi.org/10.18632/oncotarget.7308 |
Ejemplares similares
-
Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.
por: Kawamata, H., et al.
Publicado: (1998) -
Identification of Binding Proteins for TSC22D1 Family Proteins Using Mass Spectrometry
por: Kamimura, Ryouta, et al.
Publicado: (2021) -
TSC22 in mammary gland development and breast cancer
por: Huser, C, et al.
Publicado: (2008) -
Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line
por: Omotehara, F, et al.
Publicado: (2002) -
Transforming Stimulated Clone 22 (TSC-22) Interacts Directly with
Bromodomain-Containing Protein 7 (BRD7) to Enhance the Inhibition of
Extracellular Signal-Regulate Kinase (ERK) Pathway in Ovarian
Cancer
por: Lee, Seung-Hoon, et al.
Publicado: (2022)